233
Views
15
CrossRef citations to date
0
Altmetric
Letter to the Editor

Lenalidomide-associated hypothyroidism

, &
Pages 2465-2467 | Received 17 Jul 2007, Accepted 23 Sep 2007, Published online: 01 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Ming Y. Lim, Jay S. Raval, Kristy L. Richards, Joshua F. Zeidner & Matthew C. Foster. (2015) Lenalidomide-associated hemolytic anemia. Leukemia & Lymphoma 56:9, pages 2717-2719.
Read now
Peter H Wiernik. (2013) Lenalidomide in lymphomas and chronic lymphocytic leukemia. Expert Opinion on Pharmacotherapy 14:4, pages 475-488.
Read now
Prerna Mewawalla & Constantin A Dasanu. (2011) Immune alterations in untreated and treated myelodysplastic syndrome. Expert Opinion on Drug Safety 10:3, pages 351-361.
Read now

Articles from other publishers (12)

Wade T. Iams, Megan L. Hames, Judy P. Tsai, Kimberly B. Dahlman, Mahsa S. Talbott, Kristy L. Richards & Nishitha M. Reddy. (2015) Increased serum tumor necrosis factor α levels in patients with lenalidomide-induced hypothyroidism. Experimental Hematology 43:2, pages 74-78.
Crossref
F. Pasquet, M. Pavic, J. Ninet & A. Hot. (2014) Maladies auto-immunes et cancers. Deuxième partie : maladies auto-immunes au cours des cancers et de leur traitement. La Revue de Médecine Interne 35:10, pages 656-663.
Crossref
Francesco TorinoAgnese BarnabeiRosamaria ParagliolaRoberto BaldelliMarialuisa AppetecchiaSalvatore Maria Corsello. (2013) Thyroid Dysfunction as an Unintended Side Effect of Anticancer Drugs. Thyroid 23:11, pages 1345-1366.
Crossref
S. Vincent Rajkumar & Robert A. Kyle. 2013. Neoplastic Diseases of the Blood. Neoplastic Diseases of the Blood 637 663 .
O.-P. R. Hamnvik, P. R. Larsen & E. Marqusee. (2011) Thyroid Dysfunction from Antineoplastic Agents. JNCI Journal of the National Cancer Institute 103:21, pages 1572-1587.
Crossref
Elizabeth Bilotti, Charise L. Gleason & Ann McNeill. (2011) Routine Health Maintenance in Patients Living With Multiple Myeloma. Clinical Journal of Oncology Nursing 15:0, pages 25-40.
Crossref
Tiffany A. Richards, Page A. Bertolotti, Deborah Doss & Emily J. McCullagh. (2011) Sexual Dysfunction in Multiple Myeloma. Clinical Journal of Oncology Nursing 15:0, pages 53-65.
Crossref
M. Kathleen Figaro, Warren ClaytonJr.Jr., Chinenye Usoh, Kara Brown, Adetola Kassim, Vipul T. Lakhani & Shubhada Jagasia. (2011) Thyroid abnormalities in patients treated with lenalidomide for hematological malignancies: Results of a retrospective case review. American Journal of Hematology 86:6, pages 467-470.
Crossref
S. Vincent Rajkumar & Suzanne R. Hayman. 2011. Management of Hematologic Malignancies. Management of Hematologic Malignancies 155 183 .
Peter H. Wiernik. (2008) Treatment of Hematologic Neoplasms with New Immunomodulatory Drugs (IMiDs). Current Treatment Options in Oncology 10:1-2, pages 1-15.
Crossref
Constantin A. Dasanu & Doru T. Alexandrescu. (2009) A case of severe aplastic anemia secondary to treatment with lenalidomide for multiple myeloma. European Journal of Haematology 82:3, pages 231-234.
Crossref
. (2008) Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidemiology and Drug Safety 17:7.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.